Rakesh C Kukreja Selected Research

Glucose (Dextrose)

5/2020	Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
12/2017	Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.
2/2014	Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.
1/2012	Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rakesh C Kukreja Research Topics

Disease

44	Ischemia 05/2023 - 02/2002
38	Reperfusion Injury 12/2023 - 03/2002
37	Infarction (Infarctions) 11/2020 - 02/2002
32	Myocardial Infarction 05/2023 - 01/2006
19	Neoplasms (Cancer) 01/2023 - 05/2008
16	Heart Failure 09/2023 - 06/2007
16	Cardiotoxicity 01/2023 - 04/2005
16	Necrosis 09/2015 - 03/2002
14	Myocardial Ischemia (Ischemic Heart Diseases) 12/2023 - 01/2005
13	Erectile Dysfunction 03/2023 - 09/2002
10	Cardiomyopathies (Cardiomyopathy) 12/2014 - 04/2005
9	Inflammation (Inflammations) 05/2023 - 09/2007
8	Cardiomegaly (Heart Hypertrophy) 01/2023 - 03/2008
7	Hypoxia (Hypoxemia) 04/2015 - 12/2004
6	Body Weight (Weight, Body) 01/2023 - 01/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 02/2008
5	Insulin Resistance 03/2023 - 02/2008
5	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 10/2010
4	Fibrosis (Cirrhosis) 05/2023 - 06/2011
4	Pulmonary Arterial Hypertension 01/2023 - 04/2005
4	Left Ventricular Dysfunction 05/2012 - 04/2005
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 01/2013
3	Hypertrophy 01/2018 - 10/2010
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 07/2013
3	Heart Diseases (Heart Disease) 03/2015 - 09/2009
3	Pulmonary Hypertension 01/2011 - 02/2004
2	Infections 09/2023 - 03/2023
2	COVID-19 09/2023 - 03/2023
2	Hyperglycemia 03/2023 - 01/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 09/2015
2	Pulmonary Edema 12/2014 - 03/2008
2	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2014 - 03/2014
2	Coronary Restenosis 12/2012 - 08/2006
2	Obesity 04/2012 - 01/2012
2	Ventricular Dysfunction 05/2011 - 01/2006

Drug/Important Bio-Agent (IBA)

31	Sildenafil Citrate (Viagra)FDA Link 03/2023 - 09/2002
27	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2023 - 01/2005
18	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 04/2005
17	Phosphodiesterase 5 InhibitorsIBA 03/2023 - 04/2005
17	Tadalafil (Cialis)FDA Link 03/2023 - 02/2004
12	Sirolimus (Rapamycin)FDA Link 12/2023 - 08/2006
10	Adenosine Triphosphate (ATP)IBA 01/2017 - 09/2002
7	TOR Serine-Threonine KinasesIBA 12/2023 - 05/2015
7	Vardenafil Dihydrochloride (Levitra)FDA Link 03/2023 - 02/2004
7	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2017 - 04/2004
6	MicroRNAs (MicroRNA)IBA 12/2023 - 12/2008
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2020 - 04/2004
5	NitratesIBA 05/2020 - 05/2011
5	Proteins (Proteins, Gene)FDA Link 04/2018 - 05/2008
5	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 05/2015 - 09/2009
5	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2012 - 02/2004
5	Small Interfering RNA (siRNA)IBA 02/2012 - 10/2005
5	5-hydroxydecanoic acidIBA 01/2008 - 09/2002
4	EnzymesIBA 03/2023 - 01/2011
4	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 01/2012
4	AnthracyclinesIBA 01/2018 - 05/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015 - 12/2006
4	Trypan Blue FDA Link 05/2015 - 04/2005
4	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 03/2012 - 12/2006
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2010 - 02/2002
4	mitochondrial K(ATP) channelIBA 01/2008 - 09/2002
3	Insulin (Novolin)FDA Link 03/2023 - 02/2014
3	Gemcitabine FDA Link 12/2022 - 03/2014
3	NitritesIBA 05/2020 - 05/2011
3	Triglycerides (Triacylglycerol)IBA 12/2017 - 01/2012
3	Sirtuin 1IBA 06/2014 - 12/2010
3	salicylhydroxamic acid (SHAM)IBA 05/2008 - 04/2004
2	Messenger RNA (mRNA)IBA 12/2023 - 01/2006
2	Antimalarials (Antimalarial Agents)IBA 03/2023 - 01/2017
2	LipidsIBA 03/2023 - 05/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2023 - 01/2017
2	AndrogensIBA 01/2023 - 01/2020
2	dactolisibIBA 01/2020 - 09/2015
2	Connexin 43 (Connexin43)IBA 04/2018 - 04/2015
2	Death Domain ReceptorsIBA 01/2016 - 01/2006
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015 - 12/2006
2	Biomarkers (Surrogate Marker)IBA 02/2015 - 10/2011
2	BAY 58-2667IBA 01/2015 - 03/2012
2	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 03/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2012 - 10/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 11/2007
2	ChemokinesIBA 01/2012 - 09/2007
2	CytokinesIBA 01/2012 - 09/2007
2	Transcription Factors (Transcription Factor)IBA 08/2011 - 02/2008
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 06/2011 - 03/2008
2	Cyclic NucleotidesIBA 01/2011 - 09/2009
2	Adenosine (Adenocard)FDA LinkGeneric 09/2008 - 03/2002
2	Saline SolutionIBA 05/2008 - 01/2005
2	parecoxibIBA 11/2007 - 06/2007
2	Interleukin-8 (Interleukin 8)IBA 09/2007 - 08/2005
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2006 - 04/2005
2	triphenyltetrazoliumIBA 01/2006 - 01/2005
2	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 07/2003 - 03/2002
2	S-methylisothiopseudouroniumIBA 07/2002 - 02/2002
1	Long Noncoding RNAIBA 12/2023
1	Oxygen (Dioxygen)IBA 09/2023
1	IvabradineIBA 09/2023

Therapy/Procedure

15	Therapeutics 05/2023 - 01/2009
7	Drug Therapy (Chemotherapy) 11/2020 - 05/2012
5	Ligation 12/2014 - 03/2008